Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Revisiting the Pathological Changes of COVID-19

Introduction:On February 3, 2020, based on the pulmonary lesions of SARS and the imaging manifestations of COVID-19, the author wrote "...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Maimai’s Pathology Weekly Reading Notes Issue 16 | Immunohistochemical Markers for Diagnosing Female Genital Tract Tumors (Part 2)

Preface:In the previous article, we mainly introducedFemale reproductive tract organsthe commonly used immunohistochemical markers for ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

A Glimpse of the Whole Picture: P16/Ki-67 Dual Staining for More Accurate Cervical Cancer Screening

As is well known, cervical cancer is a major threat to women's health and life, ranking first among gynecological malignant tumors. The...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Role of MUC4 Expression in Different Tumors

Introduction:Mucin 4 (MUC4) is a transmembrane mucin synthesized and secreted by specialized cells of the gastrointestinal, respiratory...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

IHC Detection of MMR Protein Series Tweets – Clarifying the “Triangular Relationship” Between CRC, MSI, and MMR

Introduction:Mentioning MMR proteins inevitably links them to CRC. About 15-20% of hereditary CRC cases are caused by MSI, so MMR prote...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Immunohistochemical Diagnosis of Renal Epithelial Tumors (Part 5)

Introduction:In the previous four articles, we have detailed renal tumors with clear cell morphology, renal tumors with eosinophilic/on...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Clinical Significance of COX-2 Expression in Colorectal Cancer

Introduction:Colorectal cancer is one of the most common malignant tumors in the world. The incidence and mortality rates of colorectal...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

The 40th Issue of “Mai Mai” Pathology Weekly Reading Notes | Immunohistochemical Markers for Aiding Diagnosis of Dysplasia and Malignant Transformation

Introduction:In the first article of this series, we mentioned that if pathology were a martial arts world, thenroutine diagnosis would...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Application of p53 Immunohistochemistry in Gynecological Tumor Diagnosis

PrefaceThe application of immunohistochemistry has become an important and reliable evidence for pathological diagnosis and classificat...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Interpreting CD30 Immunohistochemistry Results: Negative or Positive? A Clear Guide

Immunohistochemistry has become an indispensable part of the daily work of pathologists, such as lesion diagnosis and classification, a...
Continue reading
  • «
  • ‹
  • 4
  • 5
  • 6
  • 7
  • 8
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar